NEWSROOM

PRISM DigitalMedia

SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

Apr 4, 2024

SKYX Enhances its Robust Patent Portfolio Which Now Totals over 90 Issued and Pending Patents with over 30 Issued Patents SKYX’s Patents Enable and Enhance Performance of Smart Home and AI sensors in Addition to Home Safety Sensors MIAMI, FL, April 04, 2024 - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 90 issued and pending patents in US and globally, and over 60 lighting and home décor websites, with a mission to make homes...

Xcyte Digital Corp. Purchases Assets of A+ Conferencing

Xcyte Digital Corp. Purchases Assets of A+ Conferencing

Apr 3, 2024

A+ generated US$1.4 million in annual revenue and US$207K normalized EBITDA during 2023 (unaudited) Transaction is non-dilutive to Xcyte Digital shareholders Acquisition to be funded via existing cash on hand POMPANO BEACH, FL, April 03, 2024 - Xcyte Digital Corp. (TSXV: XCYT) (“Xcyte” or the “Company”), a spatial computing, event technology aggregator and developer providing a high value, cost-effective, multi-platform subscription service to host online virtual and immersive events,...

TMSH provides a corporate update for fiscal 2024

TMSH provides a corporate update for fiscal 2024

Apr 3, 2024

Cheyenne, WY, April 03, 2024 - TransGlobal Assets Inc. (OTC: TMSH) is making significant strides in various sectors, particularly in the medical wellness, health, and pet industries. Here is a corporate update for fiscal 2024. CannaKing, whose focus is on producing high-quality products in the medical wellness and health fields, is currently in discussions with a Canadian licensed producer to create its brands in-house for both recreational and medical markets. This move could significantly...

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Apr 3, 2024

Dr. Lawal has Deep Renewable Energy Expertise in Chemical Energy Conversion Processes MILTON, NY, April 03, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, announced the election of Dr. Adeniyi Lawal to the Company’s Board of Directors effective today. Dr. Lawal is expected to eventually replace Dr. Donald F. Mowbray, the Board member with the most significant technical expertise, who has indicated that he may not stand for...

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Apr 3, 2024

Pittsburgh, PA, April 03, 2024 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that the U.S. Food and Drug Administration (“FDA”) has granted a Type C meeting request to discuss the company’s proposed Phase-2b clinical trial design for the evaluation of LP-10, an intravesical liposomal formulation of tacrolimus, as a potential treatment for...

Hollywood Star Cuts and All American Gold Corp. Announce Update of Share Buy-Back Program and Conference Call

Hollywood Star Cuts and All American Gold Corp. Announce Update of Share Buy-Back Program and Conference Call

Apr 2, 2024

Las Vegas, NV, April 2, 2024 – All American Gold Corp. (OTC. AAGC) is very excited to update the public about AAGC’s ongoing share buy-back program as well as other exciting advancements the Company has accomplished. Hollywood Star Cuts became profitable in Spring 2023 after a 2-year period of establishment, development and growth. In November of 2023 All American Gold Corp. (AAGC) instituted a program by which 20% of the corporate monthly profits would be targeted for the purpose of...

Blackboxstocks Acquisition Target Evtec Reports Revenue Increased 115% in FY2023 Projects $52 Million for FY2024

Blackboxstocks Acquisition Target Evtec Reports Revenue Increased 115% in FY2023 Projects $52 Million for FY2024

Apr 2, 2024

Revenue Continues to Accelerate, Increasing 53% in First Half of FY2024 Dallas, TX, April 02, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today released financial results for the first half of FY2024 ended December 31, 2023, for its acquisition target company, Evtec Aluminum. https://prismmarketview.com/companies/blackbox/...

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

Apr 2, 2024

BioStem CEO, Jason Matuszewski, will present on Tuesday, April 9, 2024, at 12:30 pm ET POMPANO BEACH, FLORIDA, April 2, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that it will present at the 14th Annual LD Micro Invitational Conference at the Sofitel New York on April 8-9, 2024. BioStem’s Chief Executive Officer, Jason...

Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Blackboxstocks Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2023

Apr 1, 2024

Acquisition of Evtec Progressing Toward Closing Dallas, TX, April 01, 2024 – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results for the fourth quarter and year ended December 31, 2023. https://prismmarketview.com/companies/blackbox/ Fourth Quarter and Annual Financial and Operating...

SKYX Reports Record Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

Apr 1, 2024

SKYX reports $22.4 million in cash, cash equivalents, restricted cash, available cash, and investments available for sale as of December 31, 2023, as compared to $16.8 million as of December 31, 2022 MIAMI, FL, April 01, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with 77 pending and issued patents IN THE US and globally and over 60 lighting and home décor websites, with a mission to make...

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase

Apr 1, 2024

-Project Continued Growth from Sales of AmnioWrap2®- -Financial Results Conference Call and Webcast on Monday, April 1, 2024 at 4:30 pm EDT- POMPANO BEACH, FLORIDA, April 1, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the fourth quarter and twelve months ended December 31, 2023. Jason Matuszewski, CEO of BioStem,...

6th Colombia Oil and Gas Congress 2024

Apr 1, 2024

New York City, April 01, 2024 6th Colombia Oil and Gas Congress 2024 Date and Place: July 24th and 25th, 2024, Bogota, ColombiaOrganizer: Vostock Capital Official Web site For the sixth consecutive year, Colombia Oil and Gas 2024 will attract high-level attendees, flagship oil and gas companies from Latin America, world suppliers for the industry, mines and energy ministry members, and journalists to continue networking, share ideas and experience, develop contingency plans together, and work...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Launches Pilot Program with Major Utility Provider

Mar 28, 2024

Company’s Conversational AI to Provide 3rd Party Verification for Switching Energy Providers CHICAGO, March 28, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that it has signed an agreement with a large utility services company to launch a pilot program for third party verification to switch energy providers. Vocodia’s solutions can automate this labor intensive function by deploying its...

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

Mar 27, 2024

- Acquisition of 3 Rhode Island Radiation Therapy Cancer Centers progressing toward closing- - International Cancer Center equipment upgrade completed in Ecuador, Opening new Puebla, Mexico Center in Q2- - Lease extensions signed at 4 of 10 Gamma Knife customer sites – -Sales Pipeline continues to advance- -Conference Call Thursday, March 28th at 12:00 pm ET / 9:00 am PT - SAN FRANCISCO, CA, March 27, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company") a leading...

Vocodia Launches Pilot Program with Major Utility Provider

CORRECTION – Vocodia Announces Founder and Management Team Investments in Company IPO

Mar 27, 2024

In a release issued under the same headline yesterday, March 26th, please note that the date of Vocodia's IPO completion should be February 26th, not February 22nd, as previously stated. The corrected release follows: CHICAGO, March 27, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was...

SKYX Announces Corporate Update Call

Mar 27, 2024

Company to Present Fourth Quarter and 2023 Full Year Financial Results; Conference Call on April 1st, 4:30 PM EST MIAMI, FL, March 27, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that it will host a Corporate Update...

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Sono-Tek to Present at The LD Micro Invitational XIV

Mar 27, 2024

Presentation on Tuesday, April 9, 2024, at 8:30 am ET MILTON, NY, March 27, 2024 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in half-hour increments, as well as private 1:1 meetings. Sono-Tek is scheduled to present on Tuesday, April 9,...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Holdings’ AI Technology Featured in USA Today

Mar 27, 2024

Article highlights Company’s AI-Driven Solutions to Call Center Challenges CHICAGO, March 27, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, has been recognized in a USA Today article for its innovative solutions that aim to enhance the customer service experience by eliminating call center hold times. The piece, titled “Vocodia’s Conversational AI Eliminates Call Center Hold Times,” highlights the...

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO

Mar 26, 2024

Dr. Bates, Pioneering Neurosurgeon and Philanthropist, passed on March 19, 2024 SAN FRANCISCO, CA, March 26, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that Company Founder, former Chairman and Chief Executive Officer, and Board Director, Ernest A. Bates, M.D, passed away on Tuesday, March 19th at the age of...

Vocodia Launches Pilot Program with Major Utility Provider

Vocodia Announces Founder and Management Team Investments in Company IPO

Mar 26, 2024

CHICAGO, March 26, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that the Company’s senior management team invested in Vocodia’s Initial Public Offering (“IPO”) that was completed on February 22, 2024. Brian Podolak, Co-Founder, Chief Executive Officer and Director of Vocodia, invested $400,000 through the purchase of 94,117 units of the IPO. James Sposato, Co-Founder, Chief...

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

Mar 25, 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...

Nutra Pharma Corp. Reaches Settlement with SEC

Mar 22, 2024

Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 - Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean...

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

Mar 22, 2024

Conference Call on Thursday, March 28th at 12:00 pm ET / 9:00 am PT SAN FRANCISCO, CA, March 22, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its fourth quarter 2023 financial results on Thursday, March 28th at 12:00 pm ET / 9:00 am PT. The fourth quarter...

TMSH provides a corporate update for fiscal 2024

TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture

Mar 21, 2024

Cheyenne, WY, March 21, 2024 - TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health Sciences Inc., has entered into a Joint Venture Agreement with Better Health Sciences For Pets Corp., otherwise known as the Better Pets brand. This Joint Venture agreement outlines a strategic collaboration focused on marketing and distributing new key products from Better Pets. Under the terms of the agreement, TransGlobal Assets...

BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference

BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024

Mar 21, 2024

Conference Call on Monday, April 1st, at 4:30 pm ET POMPANO BEACH, FLORIDA, March 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today that it plans to release its fourth quarter 2023 financial results post-market Monday, April 01, 2024. BioStem will host a conference call and webcast at 4:30 pm ET on Monday, April 01, 2024....

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

Mar 18, 2024

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

SKYX to Participate in the 36th Annual ROTH Conference

Mar 18, 2024

MIAMI, FL, March 18, 2024 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. Founder and...

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

Mar 7, 2024

TULSA, Okla., March 7, 2024 - Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has commenced its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $25.0 million. The Company is distributing at no charge to holders of its...

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

Mar 7, 2024

New York, N.Y., March 07, 2024 - PRISM MarketView announces the release of an insightful interview with Lipella Pharmaceuticals’ CEO, Dr. Jonathan Kaufman, discussing the company's recent regulatory accomplishments and how investors stand to benefit. Lipella Pharmaceuticals was recently granted Orphan Drug Designation by the FDA for LP-410, its drug candidate for oral Graft-versus-Host Disease (GvHD) and previously received Orphan Drug Designation for LP-10 in 2023. With these nods from the...

Free report about the status of the desalination industry in Latin America

Mar 6, 2024

New York City, March 06, 2024 Get the free report about status of desalination industry in Latin America As a preamble to the upcoming 6th Congress and Exhibition Desalination Latin America 2024, which will take place next week in Santiago de Chile on March 13th and 14th, Vostock Capital is pleased to share the results of the annual survey conducted by our research team. The survey inquired about the perspectives, trends, challenges, and opportunities for the desalination industry in the Latin...